Regular paperIntraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin
References (23)
- et al.
Induction of remission in hepatocellular carcinoma with doxorubicin
Lancet
(1978) - et al.
Effect of arterial administration of high-molecular-weight antkancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report
Eur J Cancer Clin Oncol
(1983) - et al.
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States
Cancer
(1977) - et al.
Further experience in treating patients with hepatocellular carcinoma in Uganda
Cancer
(1980) - et al.
Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial
Cancer
(1978) - et al.
Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy
Cancer
(1984) - et al.
Primary Liver Cancer. An Eastern Cooperative Oncology Group trial
Cancer
(1984) - et al.
Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects
Cancer
(1981) - et al.
Hepatocellular carcinoma. A retrospective analysis of treatment to manage disease confined to the liver
Cancer
(1988) - et al.
Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium
Cancer
(1984)
Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents
Radiology
(1985)
Cited by (0)
Copyright © 1990 Published by Elsevier Ireland Ltd.